Outcomes of Functionally Complete vs Incomplete Revascularization: Insights From the FAVOR III China Trial.
Zhang R, Wang HY, Dou K, Yin D, Zhu C, Feng L, Zhou Y, Pu J, Zhang Q, Pan H, Mi J, Ye F, Cheng X, Guo N, Guan C, Song L, Qiao S, Tu S, Xu B, Stone GW; FAVOR III China Study Group.
Zhang R, et al. Among authors: xu b.
JACC Cardiovasc Interv. 2022 Dec 26;15(24):2490-2502. doi: 10.1016/j.jcin.2022.10.014.
JACC Cardiovasc Interv. 2022.
PMID: 36543443
Free article.